Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Neoadjuvant Trial of Docetaxel (Taxotere), Carboplatin, and Capecitabine (Xeloda) in the Treatment of Early Stage Locally Advanced and Inflammatory Breast Cancer

NCT00251329 is registered in ClinicalTrials.gov with Cancer Research Network as lead sponsor.

NCT NCT00251329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00251329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Neoadjuvant Trial of Docetaxel (Taxotere), Carboplatin, and Capecitabine (Xeloda) in the Treatment of Early Stage Locally Advanced and Inflammatory Breast Cancer
Lead sponsor
Cancer Research Network
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2003
Completion date
Not reported
Enrollment
48
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer